Furthermore, the AML mice model overexpressing IL‐34, displayed accelerated disease progression, a shorter survival time, and significant subcutaneous invasion of AML cells, suggesting that IL‐34 could accelerate progression of AML [13]. Here, IL34 is linked to acute myeloid leukemia.